Copyright
©The Author(s) 2022.
World J Gastroenterol. Jul 7, 2022; 28(25): 2802-2822
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2802
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2802
SI. No. | Total number of human subjects involved in study | Demographics of the study populations | Vomiting | Diarrhea | Nausea | Remarks/study summary | Ref. |
1 | 191 | Adults (46-67 years) hospitalised, Chinese peoples, 91 patients having comorbidity | 7 (3.7%) | 9 (4.7%) | 7 (3.7%) | Identification of several risk factors and a detailed clinical course of illness for mortality of COVID-19 patients | [121] |
2 | 171 | Minor aged (1 d-15 years, hospitalised, Chinese children, no such comorbidity | 11 (6.4%) | 15 (8.8%) | NA | Report of a spectrum of illness from children infected with SARS-CoV-2 virus | [122] |
3 | 1099 | Median age group (35-58 years), hospitalised, Chinese patients without any comorbidity | 55 (5.0%) | 42 (3.8%) | 55 (5.0%) | Identification and definition of clinical characteristics and disease severity of hospitalized COVID-19 patients | [37] |
4 | 140 | Adults (25-87 year), hospitalised Chinese patients with high comorbidity | 7 (5.0%) | 18 (12.9%) | 24 (17.3%) | Report on hospitalized patients having COVID-19 with abnormal clinical manifestations (fever, fatigue, gastrointestinal symptoms, allergy) | [123] |
5 | 73 | Adults hospitalised Chinese patients, comorbidity reported | NA | 26 (35.6%) | NA | Clinical significance of SARS-CoV-2 by examining viral RNA in feces of COVID-19 patients during hospitalizations | [124] |
6 | 52 | Adults (mean age 59.7 year), critically ill ICU- admitted Chinese patients, comorbidity reported | 2 (3.8%) | NA | NA | Retrospective, single-centered, observational study on critically ill, ICU-admitted adult COVID-19 patients | [125] |
7 | 138 | Adult (median age 56 years), hospitalised Chinese patients with comorbidities | 5 (3.6%) | 14 (10.1%) | 14 (10.1%) | Clinical characteristics of COVID-19 patients in hospitalized conditions | [126] |
8 | 41 | Middle age group (41-58 years) hospitalised Chinese patients with comorbidities | NA | 1 (2.6%) | NA | Epidemiological, laboratory, clinical, and radiological features and treatment with clinical outcomes of hospitalized COVID-19 patients | [46] |
9 | 62 | Studied patients (median age 41 years) were hospitalised, Chinese ethnicity and comorbidity reported | NA | 3 (4.8%) | NA | Most common symptoms at onset of illness with clinical data in confirmed COVID-19 patients | [127] |
10 | 137 | Studied patients ( mean age 57-55) ware Chinese and hospitalised, comorbidity was also noted | NA | 11 (8%) | NA | Investigation of epidemiological history, clinical characteristics, treatment, and prognosis of COVID-19 patients | [128] |
11 | 81 | Chinese patients (mean age was 49.5 years), hospitalised with high comorbidities | 4 (4.9%) | 3 (3.7%) | NA | Report of confirmed COVID-19 patients with chest computer tomography imaging anomalies | [129] |
12 | 99 | Hospitalised, Chinese patients (average age of the patients was 55.5 years), comorbidity was reported | 1 (1%) | 2 (2.0%) | 1 (1%) | Inclusive exploration of epidemiology and clinical features of COVID-19 patients | [130] |
- Citation: Chakraborty C, Sharma AR, Bhattacharya M, Dhama K, Lee SS. Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity. World J Gastroenterol 2022; 28(25): 2802-2822
- URL: https://www.wjgnet.com/1007-9327/full/v28/i25/2802.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i25.2802